Imperial College London: Lung Diseases trials

The registry lists 22 Lung Diseases studies with Imperial College London as lead sponsor. 2 are open to participants now and 9 have results posted.

Phase 1 1Phase 2 2Phase 3 1Phase 4 2No phase 16(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• The UK Interstitial Lung Disease Long-COVID19 Study (UKILD-Long COVID): Understanding the Burden of Interstitial Lung Disease in Long COVID.RecruitingNCT05514522
• The London COPD Exacerbation CohortRecruitingNCT02755974
• Metformin to Reduce Airway Glucose in COPD PatientsCompletedNCT03651895Phase 2Results posted
• A Study to Evaluate the Anti-inflammatory Effects of Solithromycin in Chronic Obstructive Pulmonary DiseaseTerminatedNCT02628769Phase 2Results posted
• Targeted Retreatment of COPD ExacerbationsCompletedNCT02300220Phase 3Results posted
• Acute Effects of a Flutter Device in COPDCompletedNCT01832961Not applicableResults posted
• Effect of Symbicort ® on GR in Sputum in COPDCompletedNCT01787097Phase 4Results posted
• Comparison of Repetitive Magnetic Stimulation and Exercise on Quadriceps Function in COPDCompletedNCT00737698Not applicableResults posted
• The Natural History of Small Airways Physiology in Diseased and Healthy StatesCompletedNCT00677560Results posted
• Macrophage Phagocytosis in COPDCompletedNCT00298389Results posted
• Can we Reduce Hospital Attendance Without Compromising Care by the Use of Telephone ConsultationCompletedNCT00129701Not applicableResults posted
• Post COVID-19 Interstitial Lung Disease: A Study of Genetic and Environmental InteractionsCompletedNCT04987606
• London Underground Study - Health Effects of Particulate MatterCompletedNCT04614064Not applicable
• Singing for Health: Improving Experiences of Lung Disease (SHIELD Trial)CompletedNCT04034212Not applicable
• Auto-titrating Oxygen in Chronic Respiratory FailureCompletedNCT02248064Not applicable
• Angiotensin-converting Enzyme (ACE)-Inhibition and Mechanisms of Skeletal Muscle Weakness in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01014338Phase 4
• Osteoprotegerin (OPG) in Induced Chronic Obstructive Pulmonary Disease (COPD) SputumCompletedNCT00655954
• Genomic/ Proteomic/ Metabonomic Profiling in Chronic Obstructive Pulmonary Disease (COPD)WithdrawnNCT00655694
• The Use of Repetitive Magnetic Stimulation for Strength Training of the Quadriceps MuscleCompletedNCT00159367Not applicable
• Cigarette Smoke Nasal and Whole Blood Challenge in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00159341Phase 1
• Endotoxin and Inflammatory Markers in Healthy Non-Smokers and Current Smokers Including Patients With Chronic Obstructive Pulmonary Disease (COPD)WithdrawnNCT00159289Not applicable
• The Usefulness of Patients Receiving Their Own Letter After an Outpatient AttendanceCompletedNCT00129636Not applicable